Hepatitis B vaccine is a vaccine that prevents hepatitis B. The first dose is recommended within 24 hours of birth with either two or three more doses given after that. This includes those with poor immune function such as from HIV/AIDS and those born pre…
Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective.Market Analysis and In…
Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-c…
Medical Image Analysis Software Market by Type (Integrated), Images (2D, 3D, 4D), Modality (CT, MRI, PET, Ultrasound), Application (Orthopedic, Oncology, Neurology, Mammography, Dental), End User (Hospital, Diagnostic Center) - Global Forecasts to 2027
The global medical image analysis software market is projected to reach USD 4.5 Billion by 2027 from USD 3.2 Billion in 2022, at a CAGR of 7.8%. Among the factors driving the market are the growing public- and private-sector investments in the medical ima…
Global Peptide Therapeutics Market 2022-2026Technavio has been monitoring the peptide therapeutics market and it is poised to grow by $ 23.36 billion during 2022-2026, accelerating at a CAGR of 12.52% during the forecast period. Our report on the peptide …
Global Vitiligo Therapeutics Market 2022-2026Technavio has been monitoring the vitiligo therapeutics market and it is poised to grow by $ 341.35 mn during 2022-2026, accelerating at a CAGR of 4.5% during the forecast period. Our report on the vitiligo the…
Global Hairy Cell Leukemia Therapeutics Market 2022-2026Technavio has been monitoring the hairy cell leukemia therapeutics market and it is poised to grow by $ 177.85 mn during 2022-2026, accelerating at a CAGR of 6.7% during the forecast period. Our repo…
Global Behcet's Disease Therapeutics Market 2022-2026Technavio has been monitoring the Behcet's disease therapeutics market and it is poised to grow by $ 281.72 mn during 2022-2026, decelerating at a CAGR of 6.68% during the forecast period. Our report on…
Global Pulmonary Edema Therapeutics Market 2022-2026Technavio has been monitoring the pulmonary edema therapeutics market and it is poised to grow by $ 339.45 mn during 2022-2026, accelerating at a CAGR of 3.06% during the forecast period. Our report on t…
Global Chronic Fatigue Syndrome Therapeutics Market 2022-2026Technavio has been monitoring the chronic fatigue syndrome therapeutics market and it is poised to grow by $ 51.84 million during 2022-2026, accelerating at a CAGR of 4.31% during the forecast p…
Global Neurologic Disorders Therapeutics Market 2022-2026Technavio has been monitoring the neurologic disorders therapeutics market and it is poised to grow by $ 33.46 bn during 2022-2026, accelerating at a CAGR of 5.44% during the forecast period. Our re…
Global Gallbladder Cancer Therapeutics Market 2022-2026Technavio has been monitoring the gallbladder cancer therapeutics market and it is poised to grow by $ 103.57 million during 2022-2026, accelerating at a CAGR of 5.44% during the forecast period. Our …
Global Travel Vaccines Market 2022-2026Technavio has been monitoring the travel vaccines market and it is poised to grow by $ 2.44 billion during 2022-2026, accelerating at a CAGR of 8.59% during the forecast period. Our report on the travel vaccines mark…
Global Throat Cancer Therapeutics Market 2022-2026Technavio has been monitoring the throat cancer therapeutics market and it is poised to grow by $ 1.82 bn during 2022-2026, accelerating at a CAGR of 6.7% during the forecast period. Our report on the thro…
Global Fallopian Tube Cancer Therapeutics Market 2022-2026Technavio has been monitoring the fallopian tube cancer therapeutics market and it is poised to grow by $ 628.28 mn during 2022-2026, accelerating at a CAGR of 9.06% during the forecast period. Our…
Global Gynecological Cancers Therapeutics Market 2022-2026Technavio has been monitoring the gynecological cancers therapeutics market and it is poised to grow by $ 14.22 bn during 2022-2026, accelerating at a CAGR of 14.67% during the forecast period. Our…
Global Zika Virus Therapeutics Market 2022-2026Technavio has been monitoring the zika virus therapeutics market and it is poised to grow by $ 4.97 billion during 2022-2026, accelerating at a CAGR of 5.25% during the forecast period. Our report on the zika…
Global Probiotic Supplements Market In Canada 2022-2026Technavio has been monitoring the probiotic supplements market in Canada and it is poised to grow by $ 59.76 mn during 2022-2026, accelerating at a CAGR of 5.9% during the forecast period. Our report …
Global Primary Immunodeficiency Therapeutics Market 2022-2026Technavio has been monitoring the primary immunodeficiency therapeutics market and it is poised to grow by $ 3.13 bn during 2022-2026, accelerating at a CAGR of 7.73% during the forecast period.…
Global Pharmacovigilance and Drug Safety Software Market 2022-2026Technavio has been monitoring the pharmacovigilance and drug safety software market and it is poised to grow by $ 72.74 mn during 2022-2026, accelerating at a CAGR of 7.11% during the forec…